Stephanie Graff, MD, FACP, FASCO· @DrSGraff · X·· 20 小时前评分70
正文 · 机器翻译
VIKTORIA-1 试验显示，Gedatolisib + fulvestrant +/- palbociclib 相比 alpelisb + fulv，在各亚组中的中位 PFS 均显著延长（用于 CDK4/6i 治疗后的二线治疗）#ESMO26 @OncoAlert @BarbaraPistill2
137 浏览 · 5 赞 · 4 转发 · 0 回复
会议摘要
LBA16按 Rapid oral 1: Breast cancer, advanced stage 对上
VIKTORIA-1: Updated results of a randomized, open-label, phase 3 study of gedatolisib (geda) + fulvestrant (fulv) ± palbociclib (palbo) vs standard of care in patients (pts) with HR+/HER2- advanced breast cancer (ABC) (Study 2)
https://esmocongress.esmo.org来源：Stephanie Graff, MD, FACP, FASCO · x.com